![](https://investorshub.advfn.com/uicon/721636.png?cb=1652177590)
Tuesday, August 18, 2020 10:36:26 AM
Hoping to start getting some DD together on the new President, as well as what the new potential MS patent may be. I am speculating a new CEO, and potentially some sort of funding + investigative contracts may be announced at some point, as this is something the company has been trying to sort out for years now. The business plan has had a lot of potential in my opinion. Many have abandoned hope, but I think it has just taken a lot longer to get out of the woods than some expected.
"Mr. Katzaroff is in discussions with the holder of a patented treatment for Multiple Sclerosis with the intent to negotiate an exclusive perpetual license." Interesting to note here as well how closely linked Multiple Sclerosis and type 1 diabetes are, in terms of the demographic that they affect. I wonder if they are going to reignite their efforts to get Liprsostin into Phase 3 trials in contingent with the MS patent that was mentioned. Or, perhaps they truly have abandoned Liprostin and are trying to leverage the work they have done and pivot to this new business direction. Time will tell. Chart is set, bring on the PRs and volume. Good luck to all.
Recent GSTC News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 08:05:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 04:33:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/19/2024 10:13:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:21:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:32:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 08:01:04 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:39 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM